Current clinical trial costs are 82 times higher than pragmatic trial alternatives.
Traditional clinical trials cost $41,000 per participant, exceeding median annual income in many countries.
The average cost to develop a new drug is $1.6 billion, reflected in pharmaceutical pricing.
Regulatory delays contribute to an estimated 21,000-120,000 preventable deaths per decade.
Current trial eligibility criteria exclude 85% of patients with the condition being studied.
95% of known diseases lack FDA-approved treatments, with research concentrated on the remaining 5%.
The average time from discovery to widespread clinical adoption is 17 years.
An estimated 166 billion potential treatment combinations remain untested with current methodologies.
Approximately 2 billion people worldwide suffer from diseases with inadequate treatment options.
No major disease has been cured in over 44 years, highlighting the need for new research paradigms.
HUMANITY SPENDS
THAN CURING ALL DISEASES COMBINED
Adjust the slider to show how you’d split your country’s finite resources between the military (weapons and armed forces) and clinical trials to cure and treat disease.